Novel and optimized strategies for inducing fibrosis in vivo: focus on Duchenne Muscular Dystrophy

被引：0
|
作者：
Patrizia Pessina
Daniel Cabrera
María Gabriela Morales
Cecilia A Riquelme
Jaime Gutiérrez
Antonio L Serrano
Enrique Brandan
Pura Muñoz-Cánoves
机构：
[1] CIBER on Neurodegenerative Diseases (CIBERNED),Cell Biology Group, Department of Experimental and Health Sciences
[2] Pompeu Fabra University (UPF),Department of Cell and Molecular Biology
[3] Catholic University of Chile,undefined
[4] Institució Catalana de Recerca i Estudis Avançats (ICREA),undefined
来源：
Skeletal Muscle | / 4卷
关键词：
Duchenne Muscular Dystrophy; Connective Tissue Growth Factor; Tibialis Anterior; Tibialis Anterior Muscle; Duchenne Muscular Dystrophy Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Targeting Fibrosis in Duchenne Muscular Dystrophy
    Zhou, Lan
    Lu, Haiyan
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (08) : 771 - 776
  • [2] Emerging Strategies in the Treatment of Duchenne Muscular Dystrophy
    Shieh, Perry B.
    NEUROTHERAPEUTICS, 2018, 15 (04) : 840 - 848
  • [3] Emerging Strategies in the Treatment of Duchenne Muscular Dystrophy
    Perry B. Shieh
    Neurotherapeutics, 2018, 15 : 840 - 848
  • [4] Current Pharmacological Strategies for Duchenne Muscular Dystrophy
    Yao, Shanshan
    Chen, Zihao
    Yu, Yuanyuan
    Zhang, Ning
    Jiang, Hewen
    Zhang, Ge
    Zhang, Zongkang
    Zhang, Baoting
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [5] Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update
    Sun, Chengmei
    Shen, Luoan
    Zhang, Zheng
    Xie, Xin
    GENES, 2020, 11 (08) : 1 - 25
  • [6] Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies
    Joe N. Kornegay
    Janet R. Bogan
    Daniel J. Bogan
    Martin K. Childers
    Juan Li
    Peter Nghiem
    David A. Detwiler
    C. Aaron Larsen
    Robert W. Grange
    Ratna K. Bhavaraju-Sanka
    Sandra Tou
    Bruce P. Keene
    James F. Howard
    Jiahui Wang
    Zheng Fan
    Scott J. Schatzberg
    Martin A. Styner
    Kevin M. Flanigan
    Xiao Xiao
    Eric P. Hoffman
    Mammalian Genome, 2012, 23 : 85 - 108
  • [7] Duchenne muscular dystrophy: Focus on pharmaceutical and nutritional interventions
    Radley, H. G.
    De Luca, A.
    Lynch, G. S.
    Grounds, M. D.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (03) : 469 - 477
  • [8] Duchenne muscular dystrophy: Focus on arachidonic acid metabolites
    Hoxha, Malvina
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 796 - 802
  • [9] A novel treatment regimen for Duchenne muscular dystrophy
    Li, Mei
    Cai, Yunting
    Zhong, Min
    Zou, Lin
    Gong, Caihui
    NEUROREPORT, 2013, 24 (16) : 924 - 927
  • [10] Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
    Angulski, Addeli Bez Batti
    Hosny, Nora
    Cohen, Houda
    Martin, Ashley A.
    Hahn, Dongwoo
    Bauer, Jack
    Metzger, Joseph M.
    FRONTIERS IN PHYSIOLOGY, 2023, 14
12345